company that has ebola vaccine
Novavax, a biotech company in the US, has developed a recombinant protein Ebola vaccine candidate based on the Guinea 2014 Ebola virus strain and has completed a Phase I human clinical trials in Australia.ovavax, a biotech company in the US, has developed a recombinant protein Ebola vaccine candidate based on the Guinea 2014 Ebola virus strain and has completed a Phase I human clinical trials in Australia.